Cargando…

Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients

BACKGROUND: Antibody-mediated immune response plays an important role in protection against reinfection. In the case of SARS-CoV-2 infection, the maximum duration of antibody response is still unknown. In this work, the generation of neutralizing  antibodies (NAbs) and IgG antibodies against the S1...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzmán-Martínez, Oscar, Guardado, Kathia, Varela-Cardoso, Miguel, Trujillo-Rivera, Alejandro, Marín-Hernández, Antonio, Ortiz-León, María Cristina, Gómez-Ñañez, Iván, Gutiérrez, Michelle, Espinosa, Rafaela, Sampieri, Clara Luz, Ramos, Celso, López-Guerrero, Delia Vanesa, Zenteno-Cuevas, Roberto, Pérez-Carreón, Julio Isael, Canales-Vázquez, Guadalupe, Montero, Hilda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525617/
https://www.ncbi.nlm.nih.gov/pubmed/34668145
http://dx.doi.org/10.1007/s15010-021-01705-7
_version_ 1784585713109434368
author Guzmán-Martínez, Oscar
Guardado, Kathia
Varela-Cardoso, Miguel
Trujillo-Rivera, Alejandro
Marín-Hernández, Antonio
Ortiz-León, María Cristina
Gómez-Ñañez, Iván
Gutiérrez, Michelle
Espinosa, Rafaela
Sampieri, Clara Luz
Ramos, Celso
López-Guerrero, Delia Vanesa
Zenteno-Cuevas, Roberto
Pérez-Carreón, Julio Isael
Canales-Vázquez, Guadalupe
Montero, Hilda
author_facet Guzmán-Martínez, Oscar
Guardado, Kathia
Varela-Cardoso, Miguel
Trujillo-Rivera, Alejandro
Marín-Hernández, Antonio
Ortiz-León, María Cristina
Gómez-Ñañez, Iván
Gutiérrez, Michelle
Espinosa, Rafaela
Sampieri, Clara Luz
Ramos, Celso
López-Guerrero, Delia Vanesa
Zenteno-Cuevas, Roberto
Pérez-Carreón, Julio Isael
Canales-Vázquez, Guadalupe
Montero, Hilda
author_sort Guzmán-Martínez, Oscar
collection PubMed
description BACKGROUND: Antibody-mediated immune response plays an important role in protection against reinfection. In the case of SARS-CoV-2 infection, the maximum duration of antibody response is still unknown. In this work, the generation of neutralizing  antibodies (NAbs) and IgG antibodies against the S1 subunit (S1 IgG ) of SARS-CoV-2 and their possible duration were determined through decay models. METHODS: 132 participants with SARS-CoV-2 infection were classified according to the severity of the disease. Seroconversion and persistence of S1 IgG antibodies and NAbs were determined by ELISA, samples were taken at two different times post-infection and duration of those antibodies was estimated using Linear Mixed Models (LMMs). RESULTS: The highest amount of S1 IgGs antibodies was associated with age (41 years or older), greater severity of COVID-19 and male gender. NAbs production was associated with the same variables, except for age. The percentage of NAbs decay is higher in the asymptomatic group (P = 0.033), while in S1 IgG antibodies decay, no statistical difference was found between the 4 severity groups. An exponential decay model was built by using a LMM and similarly, two dispersion regions where constructed. The duration of S1 IgG antibodies was 744 days (668–781) for first region and 744 days (453–1231) for the second. Regarding NAbs, an adaptative LMM was used to model a logistic function, determining a duration of 267 days (215–347). CONCLUSION: Humoral immunity to SARS-CoV-2 infection depends on the severity of the disease, gender and age. This immune response could be long-lasting as for other coronaviruses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-021-01705-7.
format Online
Article
Text
id pubmed-8525617
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-85256172021-10-20 Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients Guzmán-Martínez, Oscar Guardado, Kathia Varela-Cardoso, Miguel Trujillo-Rivera, Alejandro Marín-Hernández, Antonio Ortiz-León, María Cristina Gómez-Ñañez, Iván Gutiérrez, Michelle Espinosa, Rafaela Sampieri, Clara Luz Ramos, Celso López-Guerrero, Delia Vanesa Zenteno-Cuevas, Roberto Pérez-Carreón, Julio Isael Canales-Vázquez, Guadalupe Montero, Hilda Infection Original Paper BACKGROUND: Antibody-mediated immune response plays an important role in protection against reinfection. In the case of SARS-CoV-2 infection, the maximum duration of antibody response is still unknown. In this work, the generation of neutralizing  antibodies (NAbs) and IgG antibodies against the S1 subunit (S1 IgG ) of SARS-CoV-2 and their possible duration were determined through decay models. METHODS: 132 participants with SARS-CoV-2 infection were classified according to the severity of the disease. Seroconversion and persistence of S1 IgG antibodies and NAbs were determined by ELISA, samples were taken at two different times post-infection and duration of those antibodies was estimated using Linear Mixed Models (LMMs). RESULTS: The highest amount of S1 IgGs antibodies was associated with age (41 years or older), greater severity of COVID-19 and male gender. NAbs production was associated with the same variables, except for age. The percentage of NAbs decay is higher in the asymptomatic group (P = 0.033), while in S1 IgG antibodies decay, no statistical difference was found between the 4 severity groups. An exponential decay model was built by using a LMM and similarly, two dispersion regions where constructed. The duration of S1 IgG antibodies was 744 days (668–781) for first region and 744 days (453–1231) for the second. Regarding NAbs, an adaptative LMM was used to model a logistic function, determining a duration of 267 days (215–347). CONCLUSION: Humoral immunity to SARS-CoV-2 infection depends on the severity of the disease, gender and age. This immune response could be long-lasting as for other coronaviruses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-021-01705-7. Springer Berlin Heidelberg 2021-10-19 2022 /pmc/articles/PMC8525617/ /pubmed/34668145 http://dx.doi.org/10.1007/s15010-021-01705-7 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Guzmán-Martínez, Oscar
Guardado, Kathia
Varela-Cardoso, Miguel
Trujillo-Rivera, Alejandro
Marín-Hernández, Antonio
Ortiz-León, María Cristina
Gómez-Ñañez, Iván
Gutiérrez, Michelle
Espinosa, Rafaela
Sampieri, Clara Luz
Ramos, Celso
López-Guerrero, Delia Vanesa
Zenteno-Cuevas, Roberto
Pérez-Carreón, Julio Isael
Canales-Vázquez, Guadalupe
Montero, Hilda
Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients
title Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients
title_full Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients
title_fullStr Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients
title_full_unstemmed Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients
title_short Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients
title_sort generation and persistence of s1 igg and neutralizing antibodies in post-covid-19 patients
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525617/
https://www.ncbi.nlm.nih.gov/pubmed/34668145
http://dx.doi.org/10.1007/s15010-021-01705-7
work_keys_str_mv AT guzmanmartinezoscar generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT guardadokathia generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT varelacardosomiguel generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT trujilloriveraalejandro generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT marinhernandezantonio generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT ortizleonmariacristina generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT gomeznanezivan generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT gutierrezmichelle generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT espinosarafaela generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT sampiericlaraluz generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT ramoscelso generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT lopezguerrerodeliavanesa generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT zentenocuevasroberto generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT perezcarreonjulioisael generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT canalesvazquezguadalupe generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients
AT monterohilda generationandpersistenceofs1iggandneutralizingantibodiesinpostcovid19patients